Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Dysplastic Nevus Syndrome, Hereditary

methotrexate has been researched along with Dysplastic Nevus Syndrome, Hereditary in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Chen, SK; Desai, RJ; Gautam, N; Glynn, RJ; He, M; Kim, SC; Lee, H; Vine, SM; Weinblatt, ME1
Mar, VJ; Wang, C; Wluka, AE; Wolfe, R; Yan, MK1
Egeberg, A; Gillstedt, M; Kristensen, K; Polesie, S; Pottegård, A; Schmidt, SAJ1
Kato, Y; Yamamoto, T1
Gillstedt, M; Osmancevic, A; Paoli, J; Polesie, S; Sönnergren, HH1

Reviews

1 review(s) available for methotrexate and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
Association Between Low-Dose Methotrexate Exposure and Melanoma: A Systematic Review and Meta-analysis.
    JAMA dermatology, 2022, Oct-01, Volume: 158, Issue:10

    Topics: Arthritis, Rheumatoid; Humans; Melanoma; Melanoma, Cutaneous Malignant; Methotrexate; Psoriasis

2022

Other Studies

4 other study(ies) available for methotrexate and Dysplastic Nevus Syndrome, Hereditary

ArticleYear
Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
    Clinical and experimental rheumatology, 2023, Volume: 41, Issue:1

    Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cohort Studies; Humans; Hydroxychloroquine; Melanoma; Melanoma, Cutaneous Malignant; Methotrexate; Skin Neoplasms

2023
Use of methotrexate and risk of skin cancer: a nationwide case-control study.
    British journal of cancer, 2023, Volume: 128, Issue:7

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Case-Control Studies; Humans; Melanoma, Cutaneous Malignant; Methotrexate; Psoriasis; Risk Factors; Skin Neoplasms

2023
Superficial spreading melanoma in a psoriatic plaque of a patient with psoriatic arthritis.
    The Journal of dermatology, 2016, Volume: 43, Issue:10

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Psoriatic; Back Pain; Biopsy; Cholecalciferol; Dendritic Cells; Female; Humans; Immunohistochemistry; Melanoma; Melanoma, Cutaneous Malignant; Methotrexate; Middle Aged; Ointments; PUVA Therapy; Retinoids; Severity of Illness Index; Skin Neoplasms

2016
Methotrexate treatment and risk for cutaneous malignant melanoma: a retrospective comparative registry-based cohort study.
    The British journal of dermatology, 2017, Volume: 176, Issue:6

    Topics: Adult; Age Distribution; Aged; Female; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Male; Melanoma; Melanoma, Cutaneous Malignant; Methotrexate; Middle Aged; Registries; Retrospective Studies; Risk Factors; Sex Distribution; Skin Neoplasms; Sweden

2017